Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Oncolytics Biotech Inc (ONCY)

Oncolytics Biotech Inc (ONCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032 Newswire.ca - Fri May 3, 11:15AM CDT

/CNW/ -- According to a "highly troubling" new study, the rising number of cancer cases in young people is being attributed to "accelerated aging." Further...

ONCY : 1.1700 (unch)
CELC : 17.67 (+0.06%)
OLMA : 10.67 (+5.96%)
BIO : 279.83 (+0.19%)
AZN : 76.35 (+0.73%)
ONC.TO : 1.60 (+0.63%)
Biotech's Developments in Race Against Rising Cancer Rates Revealed BayStreet.ca - Fri May 3, 10:46AM CDT

USA News Group – According to a “highly troubling” new study, the rising number of cancer cases in young people is being attributed to “accelerated aging.” Further alarm is being spread by the...

ONCY : 1.1700 (unch)
ONC.TO : 1.60 (+0.63%)
CELC : 17.67 (+0.06%)
OLMA : 10.67 (+5.96%)
BIO : 279.83 (+0.19%)
AZN : 76.35 (+0.73%)
As Early-Onset Breast Cancer Cases Soar in North America and EU, Biotech Ramps Up Response Newswire.ca - Tue Apr 30, 9:30AM CDT

/CNW/ -- USA News Group – An alarming rise in early-onset cancers has medical experts very concerned, as cancer cases in younger people are rising sharply. In...

ONCY : 1.1700 (unch)
ICCM : 1.1900 (+0.85%)
ATOS : 1.6600 (+9.21%)
ARVN : 32.82 (+1.20%)
PFE : 27.81 (+0.40%)
ONC.TO : 1.60 (+0.63%)
Biotech Firms Intensify Efforts as Breast Cancer Strikes Younger Patients at Alarming Rate BayStreet.ca - Tue Apr 30, 9:04AM CDT

USA News Group – An alarming rise in early-onset cancers has medical experts very concerned, as cancer cases in younger people are rising sharply. In particular, a surge in cases of breast cancer is...

ONCY : 1.1700 (unch)
ONC.TO : 1.60 (+0.63%)
ICCM : 1.1900 (+0.85%)
ATOS : 1.6600 (+9.21%)
ARVN : 32.82 (+1.20%)
PFE : 27.81 (+0.40%)
Oncolytics Biotech® to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights Newswire.ca - Tue Apr 30, 6:00AM CDT

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced that...

ONCY : 1.1700 (unch)
ONC.TO : 1.60 (+0.63%)
Oncolytics Biotech® Announces Upcoming Presentations at the American Society of Clinical Oncology Annual Meeting Newswire.ca - Thu Apr 25, 6:00AM CDT

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced the...

ONCY : 1.1700 (unch)
ONC.TO : 1.60 (+0.63%)
Biotech Breakthroughs Spearhead Fight Against Rising Breast Cancer Cases BayStreet.ca - Thu Apr 11, 8:49AM CDT

USA News Group – The American Cancer Society is projecting 2024 to be the first year ever for the US to have more than 2 million new cases, which would represent a record high. Among 10 of the most common...

ONCY : 1.1700 (unch)
ONC.TO : 1.60 (+0.63%)
GILD : 64.78 (-0.84%)
GTHX : 4.49 (+1.13%)
AZN : 76.35 (+0.73%)
HOLX : 76.54 (+0.83%)
Biotech Innovations Paving the Way in Breast Cancer Fight FinancialNewsMedia - Thu Apr 11, 8:15AM CDT

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GILD),(NASDAQ:GTHX),(NASDAQ:AZN),(NASDAQ:HOLX) EQNX::TICKER_END

ONCY : 1.1700 (unch)
ONC.TO : 1.60 (+0.63%)
GILD : 64.78 (-0.84%)
GTHX : 4.49 (+1.13%)
AZN : 76.35 (+0.73%)
HOLX : 76.54 (+0.83%)
Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA FinancialNewsMedia - Thu Apr 11, 7:27AM CDT

Requested for Q2 2024, the Type C meeting is to focus on planned registration-enabling trial in HR+/HER2- metastatic breast cancer Overall survival results from the randomized HR+/HER2- metastatic breast...

ONCY : 1.1700 (unch)
ONC.TO : 1.60 (+0.63%)
Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA Newswire.ca - Thu Apr 11, 6:00AM CDT

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapeutics for oncology, is pleased to...

ONCY : 1.1700 (unch)
ONC.TO : 1.60 (+0.63%)

Barchart Exclusives

3 High-Yield Dividend Stocks Ready to Soar Barchart - Fri May 3, 6:00PM CDT
These three stocks are cheap, pay a high dividend, and are highly rated. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot